查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855921

2025年全球医疗保健总体基因体学市场报告

Metagenomics In Healthcare Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医疗保健领域总体基因体学的市场规模迅速扩张，从2024年的20.7亿美元成长到2025年的24.4亿美元，复合年增长率达17.9%。这一增长主要得益于生物资讯学工具在分析复杂元基因组数据方面的应用日益广泛、对快速准确病原体检测方法的需求不断增长，以及总体基因体学在药物发现和生物标誌物鑑定方面的应用日益增多。

预计未来几年，医疗保健领域的总体基因体学市场将快速成长，到2029年市场规模将达到46.6亿美元，复合年增长率（CAGR）为17.6%。预测期内的增长可归因于感染疾病病率的上升、对精准医疗需求的增加、利用总体基因体学进行抗菌素抗药性监测的日益重视、总体基因体学学在肿瘤研究和诊断中应用范围的扩大，以及人们对基于微生物组的治疗和干预措施的认识不断提高。预测期内的关键趋势包括定序平台的技术进步、生物资讯学流程的创新、单细胞总体基因体学的发展、微生物组疗法的研发以及人工智慧在数据分析中的应用。

在医疗保健领域，总体基因体学是指分析直接从临床或环境样本中获得的遗传物质，无需培养即可研究整个微生物群落。它有助于识别病原体、研究微生物组组成并检测与疾病相关的微生物变化，从而实现精准诊断、个人化治疗和加强感染控制。

医疗保健领域的主要总体基因体学类型包括样本萃取试剂套件和总体基因体学套件。样本萃取试剂套件是市售工具，旨在高效可靠地从生物样本中分离去氧核糖核酸)或核糖核酸 (rRNA)。它们采用次世代定序、聚合酵素链锁反应)和微阵列等技术，并遵循包括样本采集、 去氧核糖核酸萃取、文库建构和定序在内的工作流程。这些试剂盒应用于感染疾病诊断、基因组流行病学、个人化医疗、微生物组分析和药物研发等领域，服务医院、诊断实验室、研究机构、製药公司和生物技术公司等终端用户。

美国在2025年春季突然提高关税，由此引发的贸易摩擦对医疗保健产业造成了严重衝击，尤其对关键医疗设备、诊断试剂和药品的供应造成了严重影响。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的紧张，导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税也阻碍了必需药品和医疗设备的生产，造成供应链瓶颈。为了应对这项挑战，医疗产业正在积极调整筹资策略，尽可能地促进本地生产，并呼吁对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司（The Business Research Company）最新发布的医疗保健总体基因体学市场统计系列报告之一，为您提供在医疗保健总体基因体学学行业取得成功所需的关键数据，包括全球医疗保健总体基因体学市场规模、区域份额、市场份额总体基因体学、详细的市场总体基因体学、市场趋势和商业机会。本医疗保健总体基因体学市场研究报告对该行业的现状和未来发展趋势进行了深入分析，为您提供全面观点所需的一切资讯。

感染疾病日益普遍预计将推动医疗保健领域总体基因体学市场的成长。感染疾病是由有害微生物（例如细菌、病毒、真菌和寄生虫）引起的疾病，可透过直接或间接途径在人与人之间传播。感染疾病流行率的上升主要是由于旅行的增加，这加速了病原体在不同地区和国家之间的传播。总体基因体学在医疗保健领域发挥关键作用，它能够快速且准确地识别病原体，从而在对抗这些疾病方面至关重要，对于控制感染疾病疫情至关重要。分析复杂的微生物群落可以减少诊断的不确定性，改善患者预后，并有助于制定标靶治疗方法。例如，英国卫生安全局在2024年2月报告称，英格兰的结核病病例将在2023年增加10.7%，达到4850例，而2022年为4380例。因此，感染疾病日益普遍正在推动医疗保健领域总体基因体学市场的扩张。

医疗保健领域总体基因体学市场的主要企业正在开发创新解决方案，例如微生物群落分析。该技术利用定序和生物资讯工具，对给定样本中的微生物群落进行全面分析，并评估其组成、多样性和功能。例如，2024年8月，华大基因科技有限公司推出了人类微生物组总体基因体学定序软体套件。该软体包提供了一个自动化的端到端微生物群落分析工作流程，有助于分析人类微生物组的多样性及其与各种疾病的关联。该软体包减少了人工操作，提高了结果的可重复性，并降低了成本，使大规模临床微生物组研究更容易进行。研究人员受益于更快、更准确的微生物鑑定和可调整的通量，有助于生物标记的发现并推进转化医学研究。

2025年5月，总部位于印度的基因组学和诊断公司Mapmygenome India Limited收购了Microbiome Insights Inc.，以扩展其微生物组测序和分析能力。透过此次收购，Mapmygenome旨在加强在北美市场的地位，并提升其在个人化医疗、基因组学和研究服务方面的实力。总部位于加拿大的Microbiome Insights Inc.专注于医疗保健应用的元基因组分析。

医疗保健领域的总体基因体学市场由提供生物资讯分析、微生物诊断和药物研发支援等服务的营业单位所获得的收入组成。市场价值还包括服务供应商销售的或包含在其服务产品中的相关商品的价值。医疗保健领域的总体基因体学市场还包括定序平台、试剂、耗材和生物资讯工具的销售。该市场的价值为“出厂价”，即商品製造商或创造者销售的商​​品价值，无论销售对像是其他营业单位（包括下游製造商、经销商、分销商和零售商）还是直接销售给最终客户。该市场中的商品价值也包括商品创造者提供的相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球医疗保健中的总体基因体学：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球医疗保健总体基因体学市场：成长率分析
  • 全球医疗保健总体基因体学市场表现：规模与成长，2019-2024年
  • 全球医疗保健总体基因体学市场预测：规模和成长，2024-2029年，2034年预测
  • 全球医疗保健总体基因体学：潜在市场规模 (TAM)

第六章 市场细分

  • 总体基因体学学市场：按类型、表现和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 样本萃取试剂套件
  • 总体基因体学套件
  • 全球医疗保健总体基因体学市场：依技术、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 次世代定序仪
  • 聚合酵素链锁反应
  • 微阵列
  • 全球医疗保健总体基因体学市场：依工作流程划分，实际数据和预测数据，2019-2024年、2024-2029年预测数据、2034年预测数据
  • 样本采集
  • 去氧核糖核酸萃取
  • 图书馆准备
  • 定序
  • 全球医疗保健总体基因体学市场：按应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 感染疾病诊断
  • 基因组流行病学
  • 个人化医疗
  • 微生物组分析
  • 药物发现
  • 总体基因体学市场：依最终用户划分，实际数据和预测数据，2019-2024年、2024-2029年预测数据、2034年预测数据
  • 医院
  • 诊断实验室
  • 研究所
  • 製药公司
  • 生技公司
  • 全球医疗保健总体基因体学市场：按样本提取试剂套件、类型细分，实际值和预测值（2019-2024 年、2024-2029 年预测值、2034 年预测值）。
  • 去氧核糖核酸萃取试剂套件
  • 核糖核酸萃取试剂套件
  • 蛋白质萃取试剂套件
  • 总体基因体学市场：总体基因体学套件、类型、实际值和预测值（2019-2024 年、2024-2029 年预测值、2034 年预测值）进行细分
  • 图书馆准备套件
  • 定序试剂套件
  • 标靶富集试剂套件

第七章 区域和国家分析

  • 总体基因体学学市场：区域分析、预测与成长，2019-2024年、2024-2029年预测、2034年预测
  • 总体基因体学市场：国家、表现及预测，2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 医疗保健领域的总体基因体学市场：竞争格局
  • 医疗保健领域的总体基因体学市场：公司概况
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • QIAGEN NV
  • BGI Genomics Co. Ltd.
  • Novogene Corporation
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California Inc.
  • MedGenome Labs Limited
  • Zymo Research Corporation
  • BaseClear BV
  • Psomagen Inc.
  • Karius Inc.
  • Microsynth AG
  • Macrogen Inc.
  • Norgen Biotek Corp.
  • Tiny Health Inc.
  • CosmosID Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年医疗保健领域总体基因体学市场：提供新机会的国家
  • 2029年医疗保健领域总体基因体学市场：提供新机会的细分市场
  • 2029年医疗保健领域总体基因体学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38573

Metagenomics in healthcare is the analysis of genetic material obtained directly from clinical or environmental samples to study entire microbial communities without the need for culturing. It aids in identifying pathogens, examining microbiome composition, and detecting disease-associated microbial changes, enabling accurate diagnosis, personalized therapy, and enhanced infection management.

The main types of metagenomics in healthcare are sample extraction kits and metagenomics kits. Sample extraction kits are commercially available tools designed to efficiently and reliably isolate deoxyribonucleic acid or ribonucleic acid from biological samples. It employs technologies such as next-generation sequencing, polymerase chain reaction, and microarray, and follows workflows including sample collection, deoxyribonucleic acid extraction, library preparation, and sequencing. It is applied in infectious disease diagnosis, genomic epidemiology, personalized medicine, microbiome analysis, and drug discovery, serving end users including hospitals, diagnostic laboratories, research institutes, pharmaceutical companies, and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The metagenomics in healthcare market research report is one of a series of new reports from The Business Research Company that provides metagenomics in healthcare market statistics, including metagenomics in the healthcare industry's global market size, regional shares, competitors with a metagenomics in healthcare market share, detailed metagenomics in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics in healthcare industry. This metagenomics in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to rising adoption of bioinformatics tools to analyze complex metagenomic data, increasing need for rapid and accurate pathogen detection methods, and growing use of metagenomics in drug discovery and biomarker identification.

The metagenomics in healthcare market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to increasing prevalence of infectious diseases, rising demand for precision medicine, greater focus on antimicrobial resistance surveillance using metagenomics, expanding applications of metagenomics in oncology research and diagnostics, and growing awareness of microbiome-based therapies and interventions. Major trends in the forecast period include technological advancements in sequencing platforms, innovations in bioinformatics pipelines, developments in single-cell metagenomics, research and development in microbiome therapeutics, and integration of artificial intelligence in data analysis.

The increasing prevalence of infectious diseases is expected to drive the growth of the metagenomics in healthcare market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The rise in infectious disease prevalence is largely due to increased travel, which accelerates the spread of pathogens across regions and countries. Metagenomics in healthcare plays a crucial role in combating these diseases by enabling the rapid and accurate identification of pathogens, making it essential for managing infectious outbreaks. It reduces diagnostic uncertainty by analyzing complex microbial communities, improving patient outcomes, and facilitating targeted treatment approaches. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose by 10.7% in 2023, reaching 4,850 cases compared to 4,380 in 2022. Consequently, the growing prevalence of infectious diseases is driving the expansion of the metagenomics in healthcare market.

Leading companies in the metagenomics in healthcare market are developing innovative solutions, such as microbial community profiling. This method involves the comprehensive analysis of microbial populations in a specific sample, using sequencing and bioinformatics tools to assess their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a biotechnology company based in China, launched a Human Microbiome Metagenomics Sequencing Package. This package offers an automated, end-to-end workflow for microbial community profiling, making it easier to analyze human microbiome diversity and its link to various diseases. The package reduces manual labor, enhances reproducibility, and lowers costs, making large-scale and clinical microbiome research more accessible. Researchers benefit from faster and more precise microbial identification, as well as adaptable throughput, which aids in biomarker discovery and advances translational health research.

In May 2025, Mapmygenome India Limited, a genomics and diagnostics company based in India, acquired Microbiome Insights Inc. to expand its microbiome sequencing and analysis capabilities. With this acquisition, Mapmygenome aims to strengthen its presence in the North American market and enhance its offerings in personalized health, genomics, and research services. Microbiome Insights Inc., based in Canada, specializes in metagenomics for healthcare applications.

Major players in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc.

North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metagenomics in healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metagenomics in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metagenomics in healthcare market consists of revenues earned by entities by providing services such as bioinformatics analysis, microbial diagnostics, and drug discovery support. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomics in the healthcare market also includes sales of sequencing platforms, reagents, consumables, and bioinformatics tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metagenomics In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metagenomics in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metagenomics in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metagenomics in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Types: Sample Extraction Kits; Metagenomics Kits
  • 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray
  • 3) By Workflow: Sample Collection; Deoxyribonucleic Acid Extraction; Library Preparation; Sequencing
  • 4) By Application: Infectious Disease Diagnosis; Genomic Epidemiology; Personalized Medicine; Microbiome Analysis; Drug Discovery
  • 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Biotechnology Companies
  • Subsegments:
  • 1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits; Ribonucleic Acid Extraction Kits; Protein Extraction Kits
  • 2) By Metagenomics Kits: Library Preparation Kits; Sequencing Kits; Target Enrichment Kits
  • Companies Mentioned: F. Hoffmann-La Roche AG; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; BGI Genomics Co. Ltd.; Novogene Corporation; Oxford Nanopore Technologies Limited; Pacific Biosciences of California Inc.; MedGenome Labs Limited; Zymo Research Corporation; BaseClear B.V.; Psomagen Inc.; Karius Inc.; Microsynth AG; Macrogen Inc.; Norgen Biotek Corp.; Tiny Health Inc.; CosmosID Inc.; Kanvas Biosciences Inc.; Phase Genomics Inc.; Wobble Genomics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metagenomics In Healthcare Market Characteristics

3. Metagenomics In Healthcare Market Trends And Strategies

4. Metagenomics In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Metagenomics In Healthcare Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Metagenomics In Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Metagenomics In Healthcare Market Growth Rate Analysis
  • 5.4. Global Metagenomics In Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Metagenomics In Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Metagenomics In Healthcare Total Addressable Market (TAM)

6. Metagenomics In Healthcare Market Segmentation

  • 6.1. Global Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Extraction Kits
  • Metagenomics Kits
  • 6.2. Global Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarray
  • 6.3. Global Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Collection
  • Deoxyribonucleic Acid Extraction
  • Library Preparation
  • Sequencing
  • 6.4. Global Metagenomics In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease Diagnosis
  • Genomic Epidemiology
  • Personalized Medicine
  • Microbiome Analysis
  • Drug Discovery
  • 6.5. Global Metagenomics In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • 6.6. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Sample Extraction Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid Extraction Kits
  • Ribonucleic Acid Extraction Kits
  • Protein Extraction Kits
  • 6.7. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Metagenomics Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Library Preparation Kits
  • Sequencing Kits
  • Target Enrichment Kits

7. Metagenomics In Healthcare Market Regional And Country Analysis

  • 7.1. Global Metagenomics In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Metagenomics In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metagenomics In Healthcare Market

  • 8.1. Asia-Pacific Metagenomics In Healthcare Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metagenomics In Healthcare Market

  • 9.1. China Metagenomics In Healthcare Market Overview
  • 9.2. China Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metagenomics In Healthcare Market

  • 10.1. India Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metagenomics In Healthcare Market

  • 11.1. Japan Metagenomics In Healthcare Market Overview
  • 11.2. Japan Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metagenomics In Healthcare Market

  • 12.1. Australia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metagenomics In Healthcare Market

  • 13.1. Indonesia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metagenomics In Healthcare Market

  • 14.1. South Korea Metagenomics In Healthcare Market Overview
  • 14.2. South Korea Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metagenomics In Healthcare Market

  • 15.1. Western Europe Metagenomics In Healthcare Market Overview
  • 15.2. Western Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metagenomics In Healthcare Market

  • 16.1. UK Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metagenomics In Healthcare Market

  • 17.1. Germany Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metagenomics In Healthcare Market

  • 18.1. France Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metagenomics In Healthcare Market

  • 19.1. Italy Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metagenomics In Healthcare Market

  • 20.1. Spain Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metagenomics In Healthcare Market

  • 21.1. Eastern Europe Metagenomics In Healthcare Market Overview
  • 21.2. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metagenomics In Healthcare Market

  • 22.1. Russia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metagenomics In Healthcare Market

  • 23.1. North America Metagenomics In Healthcare Market Overview
  • 23.2. North America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metagenomics In Healthcare Market

  • 24.1. USA Metagenomics In Healthcare Market Overview
  • 24.2. USA Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metagenomics In Healthcare Market

  • 25.1. Canada Metagenomics In Healthcare Market Overview
  • 25.2. Canada Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metagenomics In Healthcare Market

  • 26.1. South America Metagenomics In Healthcare Market Overview
  • 26.2. South America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metagenomics In Healthcare Market

  • 27.1. Brazil Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metagenomics In Healthcare Market

  • 28.1. Middle East Metagenomics In Healthcare Market Overview
  • 28.2. Middle East Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metagenomics In Healthcare Market

  • 29.1. Africa Metagenomics In Healthcare Market Overview
  • 29.2. Africa Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metagenomics In Healthcare Market Competitive Landscape And Company Profiles

  • 30.1. Metagenomics In Healthcare Market Competitive Landscape
  • 30.2. Metagenomics In Healthcare Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Metagenomics In Healthcare Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. BGI Genomics Co. Ltd.
  • 31.3. Novogene Corporation
  • 31.4. Oxford Nanopore Technologies Limited
  • 31.5. Pacific Biosciences of California Inc.
  • 31.6. MedGenome Labs Limited
  • 31.7. Zymo Research Corporation
  • 31.8. BaseClear B.V.
  • 31.9. Psomagen Inc.
  • 31.10. Karius Inc.
  • 31.11. Microsynth AG
  • 31.12. Macrogen Inc.
  • 31.13. Norgen Biotek Corp.
  • 31.14. Tiny Health Inc.
  • 31.15. CosmosID Inc.

32. Global Metagenomics In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metagenomics In Healthcare Market

34. Recent Developments In The Metagenomics In Healthcare Market

35. Metagenomics In Healthcare Market High Potential Countries, Segments and Strategies

  • 35.1 Metagenomics In Healthcare Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Metagenomics In Healthcare Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Metagenomics In Healthcare Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer